5336 drugs suspended hanging network, rated as the key to the development of generic drugs

"
Pharmaceutical Network Industry Dynamic" Recently, Jiangsu Province Public Resources Trading Center issued the "Notice on the publication of the suspension of the results of the classification of drugs on the Internet" shows that as many as 5,336 drugs were suspended or even revokedIn addition, the notice also said that the handling of drugs suspended in dynamic adjustment will be implemented from August 1, 2020, that is, from August 1st, 5336 drugs in Jiangsu Province medical institutions will no longer be able to purchaseit is understood that the large-scale adjustment of drugs in Jiangsu Province began on December 2, 2019", "on the implementation of the 2019 Jiangsu Province drug centralized procurement catalog drug price dynamic adjustment work notice." The range of dynamic adjustment is for the pilot expansion of unselected varieties and "2015 Jiangsu Province Drug Centralized Procurement Implementation Program" procurement catalog of some drugs, the unselected drugs contain three kinds of conditions: first, the original research drug, reference formulation, through the quality and efficacy consistency evaluation of generic drugs not selected drugs, second, not through the quality and efficacy consistency evaluation of generic drugs not selected, third, the same varieties of drugs through the quality and efficacy consistency evaluation of the production enterprises to reach more than 3, not through the quality and efficacy consistency evaluation of the generic drugs suspendedfrom the above adjustment scope can be clearly seen, since the State Office issued in February 2016 "on the development of generic drug quality and efficacy consistency evaluation of the opinion", put forward "the same varieties of drugs through the consistency evaluation of the production enterprises to reach more than 3, in the centralized procurement of drugs and other aspects of the selection of non-conformity evaluation of varieties", the implementation of generic drug quality and efficacy consistency evaluation has become an important work to improve the quality of drugsup to now, in addition to Jiangsu, Zhejiang, Jiangxi, Hubei, Shandong, Heilongjiang, Beijing, Shanghai, Guangdong and other provinces and cities, in the announced suspension of the suspension of the net drug classification treatment results notice, have been put forward to start the implementation of the same name too consistent evaluation of drug companies up to 3, no longer purchase the policy of not over-consistent evaluation varietiesfor example, on April 13, the Beijing Municipal Pharmaceutical Collection and Collection Service Center issued a Notice on the Suspension of Some of the Product Procurement Functions within the Scope of National Collections that failed to pass the Consistency Evaluation Function844 drugs were suspended on the net, the varieties are both 4 plus 7 varieties, but also the second round of national mining and expansion of the varieties, a total of 844, involving a number of well-known pharmaceutical companiesMay 28, Liaoning issued "on the suspension of some drug network procurement notice" said, according to the "National Listed Drug Catalog Collection" as of April 30, 2020 data, after publicity, is now in Liaoning Province, the network has been suspended for the non-evaluation of drugs, some of the non-reviewed drugs not listed in Liaoning Province, the scope of drug procurement, since June 1, 2020April 10, Shanghai issued a notice, clearly put forward the same variety over consistency evaluation of 3 in Shanghai Sunshine procurement platform hanging on the network of the unrated varieties, no longer medical insurance settlement, directly stop reimbursementin general, "three" has become an important critical point on whether a large number of generic drug approvals have been suspended from the networkNow with the implementation of the national collection and provincial belt collection, a large number of unrated generic drugs will be acceleratedIn the future will be out of the market 90% of generic drugs, failed to pass the consistency evaluation of generic drugs, is bound to be eliminated firstIn this case, generic drug companies need to carefully do a good job of strategy, consider their own survival strategy, as soon as possible to do a good job of transformation and upgrading Especially in a variety of small market, many competitors, over-rated enterprises full of three, can consider discontinuing production.